Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale
Abstract
Patients with delirium may fail to respond to standard therapies. Sixteen patients with management-refractory hyperactive delirium responded to adjunctive valproic acid, with complete resolution of hyperactive delirium in 13 cases. A rationale for using valproic acid in such circumstances is discussed.